Even Trump’s Own Base Thinks 79-Year-Old President Is Losing It

A Reuters/Ipsos national poll of 4,638 adults (Feb. 18–23) shows significant concerns about President Trump’s cognitive fitness: 61% say he has become erratic with age and 49% say he is not mentally sharp or able to deal with challenges. The poll indicates erosion of support even among Republicans (30% say erratic; 17% say not mentally sharp) and sharp declines among independents and Democrats on perceptions of his capability versus a Sept. 2023 poll (e.g., independents viewing him as mentally sharp fell from 53% to 36%). The White House disputes the findings, but the results underscore rising political and governance risk that investors should monitor ahead of the coming term given potential implications for policy continuity and market sentiment.

Analysis

Market structure: Political-health headlines raise short-term demand for safe-haven assets and media attention on cognitive/age-related healthcare. Expect rotation into gold (GLD) and long-duration Treasuries (TLT) on 1–5 day risk-off moves (10y yield down ~10–25 bps); niche beneficiaries include diagnostics/Alzheimer drug names (LLY, BIIB, RHHBY) where renewed public focus can lift sentiment and policy attention over months.

Risk assessment: Tail risk includes abrupt medical disclosure or sudden incapacity that could trigger a 3–8% S&P sell-off and a 30–60 bps move in long yields intraday; probability low but impact material. Near-term (days–weeks) risk centers on event cadence (debates, press releases); medium-term (3–12 months) depends on polling shifts >3–5 points that change legislative odds and regulatory risk for healthcare.

Trade implications: Tactical plays: short-duration volatility buys (VIX calls or 30-day SPX 3–5% OTM put spreads) for event risk; allocate patient exposure to LLY/BIIB (6–12 month horizon) as social/political attention can accelerate funding/regulatory focus. Rotate away from high-beta consumer discretionary into XLU/XLP and add 1–3% TLT/GLD as portfolio ballast; take profits or tighten stops if VIX falls >40% from entry.

Contrarian angles: Consensus sees only risk-off; that may be overdone — prolonged perceptions of weakness can increase political gridlock, which is pro-status-quo for markets and may benefit cyclicals if fiscal policy stalls. Historical parallel: markets weathered similar age/fitness narratives (Biden 2024) with limited long-term market disruption; therefore size defensive trades conservatively (1–3% book) and look for differential opportunities where perceptions are priced but fundamentals unchanged.

Key Decisions for Investors

• Establish a 1.5–3% tactical long in GLD (target +5–8%, stop -4%) and a 1–3% position in TLT (target: 10y yield -10–25 bps from current levels) to hedge 1–30 day political risk.
• Buy 30-day SPX 3%–5% OTM put spread sized to 0.5–1% portfolio notional (cost-limited tail hedge) ahead of next major Trump public event/debate within 7–21 days; unwind if implied vol falls >30% or SPX gap down >4%.
• Take a selective 1–2% long exposure to Eli Lilly (LLY) and Biogen (BIIB) on 3–12 month horizon to capture asymmetric upside from renewed attention to cognitive health and potential policy/funding tailwinds; use 15% stop-loss, 30–50% upside target.
• Rotate 3–5% from high-beta discretionary into defensive ETFs (XLV, XLP, XLU) over 1–4 weeks; re-balance if weekly polling moves <±2 points (signal of no structural trend).
• Monitor specific catalysts (medical disclosures, debate performance, White House health briefings) on a 0–14 day cadence; increase hedges if polling moves >3 points or if administration releases partial medical records that raise uncertainty.